Moderna shares have fallen more than 30% since January 28 after news that the Health and Human Services department is reviewing a $590m contract for bird flu vaccines approved under President Biden. The review is the latest in a series of moves by the Trump administration directed at vaccines, particularly mRNA vaccines. HSS secretary Robert F. Kennedy Jr, a critic of mRNA vaccines, testified that he was “pro-safety” rather than “anti-vaccine.” The scrutiny has raised concerns about the government’s response to diseases, including a bird flu outbreak.
A Blueprint for Retail Cyber Resilience: Evolving Tactics for Today’s Digital World
As the retail market embraces technology to improve customer experiences and boost growth, it faces an escalating wave of sophisticated cyber threats targeting customer data
